本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Teladoc Health Inc.

8.04
+0.16502.10%
成交量:95.48万
成交额:765.67万
市值:14.20亿
市盈率:-6.73
高:8.07
开:7.89
低:7.86
收:7.87
52周最高:15.21
52周最低:6.35
股本:1.77亿
流通股本:1.75亿
量比:1.87
换手率:0.55%
股息:- -
股息率:- -
每股收益(TTM):-1.1945
每股收益(LYR):-5.8702
净资产收益率:-14.18%
总资产收益率:-3.57%
市净率:1.00
市盈率(LYR):-1.37

数据加载中...

2025/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/29

重要事件披露

Form 8-K - Current report
2025/07/24

重要事件披露

Form 8-K - Current report
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/01

重要事件披露

Form 8-K - Current report
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities